Showing all 2 results
Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.
Active Ingredient Strength Primary Clinical Function Chlorthalidone USP/BP 6.25 mg / 12.5 mg The Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss. Chlorthalidone USP/BP 25 mg The High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis. Excipients Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized Starch Diluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch). Torsemide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, providing dosage flexibility for both mild hypertension and severe renal failure.
Active Ingredient Strength Primary Clinical Use Torsemide USP/Ph.Eur. 5 mg / 10 mg Standard maintenance therapy for mild-to-moderate congestive heart failure and essential hypertension. Torsemide USP/Ph.Eur. 20 mg Acute diuresis for severe hepatic cirrhosis and advanced heart failure exacerbations. Torsemide USP/Ph.Eur. 100 mg High-dose therapy specifically reserved for patients with severe chronic renal failure (CRF) and massive fluid overload. Excipients Lactose Monohydrate / Crospovidone / Magnesium Stearate Diluent / Superdisintegrant / Lubricant (Engineered for immediate, predictable gastric dissolution)
